HopeStage
Back to all studies
CompletedNCT02989727

Melancholic Features and Lamotrigine Response in Bipolar II Depression

About this title

Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine

Read the official source — NCT02989727

Researchers compared Lamotrigine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Medication studyAges 18+Canada
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Lamotrigine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
SaskatoonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNovember 2003
Recruitment status
Completed
Enrollment listed in the registry
150
Sponsor
University of Saskatchewan
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT02989727
Official title
Show the full official title

Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine: Results From an 8-week, Multicenter, Double-blind, Placebo-controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Saskatoon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Lamotrigine and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is University of Saskatchewan, a university.

Did this study involve medication?

Yes. The study involved medication, including lamotrigine and Placebos.

Who was this study for?

This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies